For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $19.89 in the prior trading day, Cellebrite DI Ltd (NASDAQ: CLBT) closed at $20.18, up 1.46%. In other words, the price has increased by $1.46 from its previous closing price. On the day, 1.05 million shares were traded. CLBT stock price reached its highest trading level at $20.41 during the session, while it also had its lowest trading level at $19.99.
Ratios:
Our goal is to gain a better understanding of CLBT by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.49 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 41.61. For the most recent quarter (mrq), Quick Ratio is recorded 1.78 and its Current Ratio is at 1.81. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on March 28, 2024, Reiterated its Buy rating but revised its target price to $13.50 from $13 previously.
BofA Securities Upgraded its Neutral to Buy on February 16, 2024, whereas the target price for the stock was revised from $9 to $12.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 29 ’24 when DAFNA GRUBER bought 10,422 shares for $20.26 per share.
AYALA BERLER SHAPIRA bought 67,560 shares of CLBT for $1,350,524 on Nov 26 ’24. On Nov 22 ’24, another insider, DANA GERNER, who serves as the Officer of the company, bought 689,231 shares for $20.18 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLBT now has a Market Capitalization of 4335532032 and an Enterprise Value of 3853178624. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.06 while its Price-to-Book (P/B) ratio in mrq is 14.08. Its current Enterprise Value per Revenue stands at 10.004 whereas that against EBITDA is 57.367.
Stock Price History:
Over the past 52 weeks, CLBT has reached a high of $21.00, while it has fallen to a 52-week low of $7.91. The 50-Day Moving Average of the stock is 11.04%, while the 200-Day Moving Average is calculated to be 44.56%.
Shares Statistics:
The stock has traded on average 1.29M shares per day over the past 3-months and 1731930 shares per day over the last 10 days, according to various share statistics. A total of 203.23M shares are outstanding, with a floating share count of 86.02M. Insiders hold about 58.66% of the company’s shares, while institutions hold 38.72% stake in the company. Shares short for CLBT as of 1731628800 were 1750503 with a Short Ratio of 1.36, compared to 1728950400 on 1425468. Therefore, it implies a Short% of Shares Outstanding of 1750503 and a Short% of Float of 1.5700001000000001.
